Communication between HIV-infected children and their caregivers about HIV medicines: a cross-sectional study in Jinja district, Uganda
Communication between HIV-infected children and their caregivers about HIV medicines: a cross-sectional study in Jinja district, Uganda
复制标题
DOI：
10.7448/ias.17.1.19012
复制
发表时间：
2014-07-17
影响因子：
6
通讯作者：
Katahoire, Anne R.
中科院分区：
文献类型：
--
作者：
Kajubi, Phoebe;Whyte, Susan;Katahoire, Anne R.
简介：感染艾滋病毒的儿童对抗逆转录病毒疗法的了解取决于与他们就其健康和药物进行公开交流。指导方针将沟通的责任分配给儿童的家庭照顾者。其他研究表明，在低收入国家接受治疗的儿童中，沟通很差，对抗逆转录病毒疗法的了解也很低。本研究试图从儿童和照顾者的角度定量描述有关艾滋病毒药物的沟通。此后，它建立了与这种沟通和儿童的知识，他们的HIV medicine.Methods：我们进行了一项横断面调查，随机抽样的394名儿童艾滋病毒治疗和他们的照顾者在9个卫生设施金贾区，乌干达。我们评估了报告的频率和内容的沟通，他们的药物以及知识的药物是什么。Logistic回归分析，以确定与通信模式和儿童的艾滋病drugs.Results的知识的因素：虽然79.6%的照顾者报告说，他们解释给儿童有关的药物，只有一半（50.8%）的儿童说，他们知道，他们正在服用艾滋病药物。年龄在15 - 17岁之间的大龄儿童在前一个月与护理人员沟通HIV药物的可能性较小（OR 0.5，95% CI 0.3 - 0.7，p = 0.002）。11 - 14岁儿童（OR 6.1，95% CI 2.8 - 13.7，p
Introduction: Knowledge of antiretroviral therapy (ART) among children with HIV depends on open communication with them about their health and medicines. Guidelines assign responsibility for communication to children's home caregivers. Other research suggests that communication is poor and knowledge about ART is low among children on treatment in low-income countries. This study sought to describe communication about medicine for HIV in quantitative terms from the perspectives of both children and caregivers. Thereafter, it established the factors associated with this communication and with children's knowledge about their HIV medicines.Methods: We undertook a cross-sectional survey of a random sample of 394 children with HIV on treatment and their caregivers at nine health facilities in Jinja District, Uganda. We assessed reported frequency and content of communication regarding their medicines as well as knowledge of what the medicines were for. Logistic regression analysis was used to determine the factors associated with communication patterns and children's knowledge of HIV medicines.Results: Although 79.6% of the caregivers reported that they explained to the children about the medicines, only half (50.8%) of the children said they knew that they were taking medicines for HIV. Older children aged 15 - 17 years were less likely to communicate with a caregiver about the HIV medicines in the preceding month (OR 0.5, 95% CI 0.3 - 0.7, p = 0.002). Children aged 11 - 14 years (OR 6.1, 95% CI 2.8 - 13.7, p